Racial and gender differences in the incidence of recurrent venous thromboembolism

Thrombosis and Haemostasis

Volumn 96, Issue 3, 2006, Pages 267-273

  White, Richard H ^a,b   Dager, William E ^a   Zhou, Hong ^a   Murin, Susan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Emergency Medicine   (United States)

Author keywords

Epidemiology; Ethnicity; Gender; Race; Recurrent thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLEEDING; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HISPANIC; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; RETROSPECTIVE STUDIES; RISK; SEX FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33748615153     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-07-0365     Document Type: Article

References (21)

1. Kyrle PA, Minar E, Bialonczyk C, et a]. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350: 2558-63.
2. Baglin T, Luddington R, Brown K, et al. High risk of recurrent venous thromboembolism in men. J Thromb Haemost 2004; 2: 2152-5.
3. Agnelli G, Becattini C, Prandoni P. Recurrent venous thromboembolism in men and women. N Engl J Med 2004; 351: 2015-8; author reply 2015-8.
4. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Archives of Internal Medicine 2000; 160: 761-8.
5. Eriksson H, Lundstrom T, Wahlander K, et al. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran. Thromb Haemost 2005; 94: 522-7.
6. Garcia-Fuster MJ, Forner MJ, Fernandez C, et al. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol Haemost Thromb 2005; 34: 6-12.
7. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Archives of Internal Medicine 2000; 160: 769-74.
8. White RH, Zhou H, Kim J, et al. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Archives of Internal Medicine 2000; 160: 2033-41.
9. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
10. Office of Statewide Health Planning and Development. State of California. Inpatient hospital discharge data. 2006. Available at: http:/ /www.oshpd.ca.gov/hqad/PatientLevel/index.htm; Accessed June 10, 2006.
11. White RH, Chew HK, Zhou H, et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 2005; 165: 1782-7.
12. Healthcare Cost and Utilization Project (HCUP). Comorbidity software, version 3.1. 2005. Available at: http://www.hcup-us.ahrq.gov/ toolssoftware/comorbidity/comorbidity.jsp; Accessed June 10, 2006.
13. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
14. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004; 57: 131-41.
15. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/ Deyo methods of comorbidity measurement in administrative data. Med Care 2004; 42: 355-60.
16. Ouellette JR, Small DG, Termuhlen PM. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg 2004; 8: 1061-7.
17. White RH, Beyth RJ, Zhou H, et al. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med 1999; 107: 414-24.
18. Open Source Epidemiologic Statistics for Public Health. Persontime2 - comparing two person-time rates. 2005. Available at: http:// www.openepi.com/Menu/OpenEpiMenu.htm; Accessed May 10, 2006.
19. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119 (Suppl 1): 176S-193S.
20. Seeman TE, Crimmins E, Huang MH, et al. Cumulative biological risk and socio-economic differences in mortality:MacArthur studies of successful aging. Soc Sci Med 2004; 58: 1985-97.
21. Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-6.